Verona Pharma plc ( VRNA) - Stock Earnings
VRNA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2025 BeforeMarket | - / -0.2200000000 | 34.2 million | - / 41.5 million | 53.2 million |
VRNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -33.8 million USD | 36.7 million USD |
| 2024Q3 | -43.0 million USD | 5.6 million USD |
| 2024Q2 | -70.9 million USD | ? USD |
| 2024Q1 | -25.8 million USD | ? USD |
| 2023Q4 | -14.3 million USD | 940056 USD |
VRNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -173.4 million USD | 42.3 million USD |
| 2023 | -54.4 million USD | 458000 USD |
| 2022 | -68.7 million USD | 458000 USD |
| 2021 | -55.6 million USD | 40.0 million USD |
| 2020 | -65.1 million USD | 2351 USD |
VRNA
Price: $64.78
52 week price:
Earnings Per Share: -2.16 USD
P/E Ratio: -26.89
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 555000
Ebitda: -10.7 millionMarket Capitalization: 4.9 billion